Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid Guidelines-Reference-Cited by-同舟云学术

Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid Guidelines

Published:2022-08 Issue:8 Volume:38 Page:1180-1188
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

White-Al Habeeb Nicole M.A.,Higgins Victoria,Venner Allison A.,Bailey Dana,Beriault Daniel R.,Collier Christine,Adeli Khosrow

Funder

Center for Sepsis Control and Care

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult;Pearson;Can J Cardiol,2021

2. A snapshot of lipid reporting practices in Canadian clinical laboratories: an urgent need for harmonization;Higgins;Can J Cardiol,2021

3. National survey of adult and pediatric reference intervals in clinical laboratories across Canada: a report of the CSCC Working Group on Reference Interval Harmonization;Adeli;Clin Biochem,2017

4. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Arnett;Circulation,2019

5. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult;Anderson;Can J Cardiol,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins;The Journal of Applied Laboratory Medicine;2024-09

2. Traditional and Novel Markers: Target of Treatment vs Marker of Risk;Canadian Journal of Cardiology;2024-08

3. Canadian Society of Clinical Chemists Harmonized Pediatric Lipid Reporting Recommendations for Clinical Laboratories;Canadian Journal of Cardiology;2024-07

4. Impact of Secondary Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta‐Analysis;Journal of the American Heart Association;2024-03-19

5. Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research;European Journal of Preventive Cardiology;2024-01-22